Here is Pharma IQ's list of the best pharmaceutical associations in the world. Look out for our recommendations of what makes them so special.
The Full Spectrum
Drug Information Association (DIA): "Providing invaluable forums to exchange vital information and discuss current issues related to healthcare products, technologies, and services"
The DIA is a neutral, global, non-profit association that provides knowledge resources across the full spectrum of medical product development. It provides access to information to advance careers, skills, and innovation in the pharmaceutical, biotechnology, medical device, and related fields.
Look out for: Just Launched! DIA NOW delivering Always-On Insights. Making the intersection of healthcare accessible anytime, anywhere, across any device.
International Society for Biological and Environmental Repositories (ISBER): "ISBER is the only global forum that addresses harmonization of scientific, technical, legal, and ethical issues relevant to repositories of biological and environmental specimens"
Through ISBER you can connect with others with an interest in biospecimen science and biobanking. They are an experienced and diverse bunch in biology, computer science, marketing, management, environmental science, medicine, etc., with similar challenges in managing collections of environmental and biological specimens.
The Committee also makes available to members information on training courses and other educational opportunities.
The BioIndustry Association (BIA): “We promote an ecosystem that enables innovative life science companies to start and grow successfully and sustainably, and we do this through Influence, Connect, Save”
Their goal is to secure the UK's position as a global hub and as a top location for innovative research and commercialisation, promoting the UK as a world-leading research base to deliver healthcare solutions that can make a difference to people's lives.
We love: The BIA works with one chosen UK charity each year: connecting them the influential thought leaders within our strong ecosystem of corporate businesses, networks, academia, and associates.
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centres and related organizations across the United States and in more than 30 other nations. In a challenging environment of economic uncertainty, critical public policy debates and the ongoing need for regulatory reform, BIO is a real advocate for biotech industry breakthroughs.
The BIO International Convention,
the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
EuropaBio: “We promote an innovative and dynamic environment for the biotech industry in Europe”
EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life, to prevent, diagnose, treat and cure diseases, to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy.
Did you know: They represent 78 corporate and associate members and bioregions, and 15 national biotechnology associations in turn representing over 1800 biotech SMEs.
Research & Development
The Pharmaceutical Research and Manufacturers of America (PhRMA)
represents U.S. pharmaceutical research and biotechnology companies that are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. PhRMA members alone invested an estimated $75 billion annually in research.
They provide current news and up-to-date reviews, particularly their resource library which gives an informative overview of the Biotech industry today and includes news and informative overviews on issues like counterfeit drugs.
Pharma IQ likes: Very current with news and up-to-date reviews, particularly resource library which gives an informative overview of Biotech industry today and includes news and informative overviews on issues like clinical trials and counterfeit drugs.
They do this by facilitating the development of next-generation process technologies and innovative technical solutions. The end result will be the continued improvement and transformation of the pharmaceutical manufacturing industry to better ensure the availability of quality medicines to patients around the world.
ISPE now has 22,000 Members in 90 countries worldwide and keeps industry professionals informed of the latest technological and regulatory trends that are occurring in the marketplace.
AAPS has approximately 12,000 members employed in industry, academia, government, and other research institutes worldwide and offers timely scientific programs, ongoing education, information resources, opportunities for networking, and professional development.
Check out their great e-learning platform
which includes an impressive backlog of webinars, offering electronic education opportunities for AAPS members and the scientific community.
The ABPI represents companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing the majority of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
Medicines for Europe
, formally known as The European Generic Medicines Association (EGA)
was initially focused on representing the emerging generics industry. They have now expanded to biosimilars and value-added medicines
. Today they “represent the pharmaceutical companies supplying the largest share of medicines across Europe and is the voice of the generic, biosimilar and value-added industries”.
Purpose and objectives: to increase the health and well-being of all Europeans through better access to high-quality medicines
Their aim is to get safe, effective, and more affordable medicines out of the lab and into the hands of the people who need them is a goal that touches not just individuals and families, but the overall economy, and the entire nation.
As manufacturers of 9 out of every 10 prescriptions dispensed in the U.S., members of the Association for Accessible Medicines form an integral, and powerful, part of the healthcare system.
The European Personalised Medicine Association (EPEMED)
is a not-for-profit organisation, which was founded to address issues in personalised medicine that confront the industry, regulators, payers & insurers as well as governments. The organisation is directed by a dynamic and diverse group of leaders in the personalised medicine field, who have great expertise in the application and development of diagnostic tools to deliver improved patient care.
Pharma IQ likes: Good regulatory guidance on the co-development of diagnostic test and personalised drug therapy